CNTB
Connect Biopharma Holdings Ltd
NASDAQ: CNTB · HEALTHCARE · BIOTECHNOLOGY
$2.53
+5.42% today
Updated 2026-04-29
Market cap
$142.43M
P/E ratio
—
P/S ratio
2,225.53x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Connect Biopharma Holdings Ltd (CNTB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-69.03M | $-13.09M | $-25.61M | $-544.93M | $-99.27M | $-47.93M | $-23.61M | $-51.21M |
| Capital expenditures | $1.19M | $155522.00 | $2.34M | $47.53M | $4.28M | $294000.00 | $750000.00 | $434000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $562173.00 | $590644.00 | $57.86M | $1.01M | $3.26M | $6.73M | $3.73M |
| Free cash flow | $-70.22M | $-13.25M | $-27.95M | $-592.46M | $-103.55M | $-48.22M | $-24.36M | $-51.64M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $243000.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |